Insiders who reported open-market trades in the last 12 months at the companies Emma Reeve files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Emma Reeve is a corporate insider of Whitehawk Therapeutics, Inc. (WHWK). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Emma Reeve last file a Form 4?
The most recent primary Form 4 on record is dated 15 June 2026, one of 7 filings going back to 2025.
Has Emma Reeve been buying or selling stock?
Recorded transactions: 0 open-market purchases and 18 open-market sales ($5.11M) across all tracked filings.
Emma Reeve files SEC Form 4 reports at Whitehawk Therapeutics, Inc. (WHWK). 7 SEC Form 4 filings on record going back to 2025, most recently on 15 June 2026. Most recent open-market trade: sold $58K of PTCT on 5 December 2025. Lifetime open-market sales: $5.11M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Emma Reeve.
InsiderAlpha's records for Emma Reeve go back to 2025: 7 primary Form 4 filings, an average of 3.5 per year. 28 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
